ロード中...
Cardiotoxicity from immune checkpoint inhibitors
Immune checkpoint inhibitor (ICI) therapy has greatly improved treatment of various advanced cancers but increasing use of ICI therapy has exposed the risk of ICI-related cardiovascular side effects. Immune checkpoints are inhibitory regulators of T cell activation and mediate T cell effector functi...
保存先:
| 出版年: | Int J Cardiol Heart Vasc |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736791/ https://ncbi.nlm.nih.gov/pubmed/31517036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2019.100420 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|